Search clinical trials for: Placebo - IV

Total 56308 results

Eli Lilly and Company

Completed

A Safety Study of Mirikizumab (LY3074828)

Psoriasis

Canada
United Therapeutics

Terminated

Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn

Persistent Pulmonary Hypertension of the Newborn

United States
Alexion

Completed

A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants

Healthy

United Kingdom
Naurex, Inc, an affiliate of Allergan plc

Completed

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Major Depressive Disorder

United States
AstraZeneca

Recruiting

A Study of AZD0486 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Follicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin Lymphoma

Korea, Republic of, United States, Japan, Taiwan, Australia
MD Stem Cells

Recruiting

Stem Cell Ophthalmology Treatment Study II (SCOTS2)

Glaucoma | Age-Related Macular Degeneration | Macular Degeneration | Retinitis Pigmentosa | Leber Hereditary Optic Neuropathy | Optic Atrophy | Blindness | Optic Neuropathy | Vision, Low | Retinal Disease | Stargardt Disease | Maculopathy | Retinopathy | Optic Nerve Disease | Nonarteritic Ischemic Optic Neuropathy | Vision... and other conditions

United States, United Arab Emirates
Sutter Gould Medical Foundation

Withdrawn

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Anemia, Iron Deficiency

United States
University of Colorado, Denver

Completed

Appetite Regulation in Older-Aged Obese Individuals

Obesity | Aging

United States
AbbVie

Completed

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC)

United States, Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Nether... and more
Credentis AG

Completed

Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions

Dental Caries

Switzerland
AbbVie
Boehringer Ingelheim

Completed

Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.

Crohn Disease
Assistance Publique - Hôpitaux de Paris

Unknown

Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies (TBF-Cord)

Leukemia, Myeloid

France
Syros Pharmaceuticals

Suspended

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia

United States
Boehringer Ingelheim

Terminated

Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

United States
Miquel Pujol
Hospital Universitari de Bellvitge

Completed

Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

Staph Aureus Methicillin Resistant Bacteremia

Spain
University of California, Los Angeles
National Institute of Neurological Disorders and Stroke (NINDS)

Terminated

Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization (HASTIER)

Acute Ischemic Stroke

United States
Yale University
National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs

Completed

Varenicline and Nicotine Interactions in Humans (VA)

Smoking Cessation

United States
Fresenius Medical Care Deutschland GmbH

Terminated

PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure

Heart Failure | Acute Heart Failure

Germany, Sweden
Coopervision, Inc.

Completed

Non-dispensing Fitting Study Comparing the Clinical Performance Hydrogel Sphere Design Contact Lenses.

Myopia

Mexico
Hoffmann-La Roche

Completed

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors (GARDENIA)

Ulcerative Colitis

Spain, United Kingdom, Belgium, Korea, Republic of, Austria, Czechia, France, Hungary, Italy, Netherlands, Singapore, Portugal, Canada, Germany, South Africa, Switzerland, Romania, Norway, Sweden, Israel
Massachusetts General Hospital
UCB Pharma

Withdrawn

Seizure Therapy With Intravenous Levetiracetam and Lorazepam (STILL)

Seizures
New York Presbyterian Brooklyn Methodist Hospital

Completed

OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure (OUTLAST)

Heart Failure
Erasme University Hospital
Jean Paul Van Vooren

Unknown

Steroids and Microcirculation In Cardiac Surgery (SICS)

Cardiac | C.Surgical Procedure

Belgium
University of California, Los Angeles
Sponsor Name Pending

Completed

Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure

Symptomatic Uterine Fibroids and Adenomyosis

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure

Healthy

United States
University of Cologne
3M

Completed

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients (COAT)

Bloodstream Infection

Germany
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Methodist Health System

Active, not recruiting

Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit (RESTART)

Gram-Negative Bacterial Infections

United States
Hoffmann-La Roche

Recruiting

A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 in Participants With Multiple Sclerosis.

Multiple Sclerosis

Belgium, Portugal, United States, Italy, Poland, Germany, Canada, Israel, Moldova, Republic of, Romania
ImCheck Therapeutics

Recruiting

First-in-Human Study of ICT01 in Patients With Advanced Cancer (EVICTION)

Hematopoietic/Lymphoid Cancer | Solid Tumor, Adult

France, Belgium, United States, Germany, Spain, United Kingdom
MD Stem Cells

Recruiting

Neurologic Stem Cell Treatment Study (NEST)

Stroke | Nervous System Diseases | Diabetic Neuropathies | Neurodegenerative Diseases | Cognitive Impairment | Amyotrophic Lateral Sclerosis | Dementia | Neurological Disorders | Alzheimer Disease | ALS | Traumatic Brain Injury | Cerebral Infarction | Lewy Body Disease | Cerebral Hemorrhage | Frontotemporal Dementia | Progressive... and other conditions

United States, United Arab Emirates
University Hospital, Geneva

Completed

Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy

Iron Induced Hypophosphatemia

Switzerland
Cedars-Sinai Medical Center

Completed

Ultrasound Guided Peripheral IV Insertion (USGPIV)

Anesthesia

United States
HealthPartners Institute

Completed

Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access

Difficult IV Access

United States
Bristol-Myers Squibb
Cardioxyl Pharmaceuticals, Inc

Completed

A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure

Heart Failure | Decompensated Heart Failure | Acute Heart Failure

United States, Germany, Jordan, Poland, Russian Federation
Denver Health and Hospital Authority

Withdrawn

RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone

Anemia | Trauma | Functional Iron Deficiency

United States
AbbVie

Recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Israel
Alnylam Pharmaceuticals

Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

TTR-mediated Amyloidosis

Portugal, Sweden, Brazil, United States, France, Spain, Germany
Boehringer Ingelheim

Completed

Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males

Healthy
Gülçin Özalp Gerçeker

Completed

Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications (nexiva)

Catheter Complications | Catheter Leakage

Turkey
Università degli Studi di Sassari

Completed

Temperament Dimensions and Awakening Salivary Cortisol Levels in ADHD.

Attention Deficit Hyperactivity Disorder

Italy
Radboud University Medical Center

Completed

Reliability of Insulin by Jet Injection

Diabetes Mellitus

Netherlands
Rush University Medical Center

Completed

Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin

Diabetes

United States
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis
Robert W. Alexander, MD, FICS
Terry, Glenn C., M.D.

Withdrawn

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy (SVF-BPN)

Nocturia | BPH | BPH With Urinary Obstruction | Prostatism | Prostate Inflammation

United States
Kaiser Permanente

Withdrawn

Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy

Depressive Disorder | Depression | Bipolar Disorder | Major Depressive Disorder | Treatment Resistant Depressive Disorder
Seattle Children's Hospital
Cystic Fibrosis Foundation

Completed

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

Cystic Fibrosis | Chronic Bronchitis

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Severe Erythema Multiforme - CORTICO (SEMCORTICO)

Erythema Multiforme
Amgen

Terminated

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Mixed Dyslipidemia | Primary Hypercholesterolemia

China
National Cardiovascular Center Harapan Kita Hospital...

Unknown

Thiamine Influenced on Substrate Energy Effectiveness in Indonesian Children Undergoing Cardiopulmonary Bypass

Cardiopulmonary Bypass | Congenital Heart Disease | Thiamine Deficiency

Indonesia

Search clinical trials for: Placebo - IV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations